Australia's most trusted
source of pharma news
Monday, 22 June 2026
Monday, 22 June 2026
Subscribe
Login
News Headlines
News Headlines
News
Pfizer's $53M drug under threat
Posted 22 June 2026 AM
The first generic version of Pfizer’s JAK inhibitor Xeljanz has been registered in Australia by Accelagen.
The TGA approved Accelagen’s generics of the 5mg strength and the 10mg strength under three brand names – Tofadoz, Tofacitinib Lupin, and MSN Tofacitinib.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (24)
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Account Manager - Sydney
- Clinical Account Manager - Melbourne
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
- Key Account Manager - Melbourne
- Senior Group Financial Accountant - Victoria
- Strategic Sales Director ANZ, Digital Health - Melbourne
- Strategic Sales Director ANZ, Digital Health - Sydney
- Sales Manager / Territory Manager - Christchurch
- Business Development Manager – Health Tech - Melbourne
- Business Development Manager – Health Tech - Brisbane
- GP Representative - Geelong
- Business Development Manager, Health Tech - Sydney
Access & Reimbursement (1)
Clinical & Medical, R&D (8)
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Clinical Trial Investigator - Melbourne
- Senior Medical Manager - Melbourne
Regulatory, Pharmacovigilance & QA (4)
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Other (9)
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- QC Analyst - Microbiology - Melbourne
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
- Talent Acquisition Coordinator - Mascot
- Portfolio Manager ANZ - Melbourne
- Director of Operations, HealthTech - Melbourne
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.